Drug Pipeline

Cisplatin for injection Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
2
Phase 3
3
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-01 NCT07618910 Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC Phase 2 Not Yet Recruiting
Active Studies by Phase
Phase 3
2
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06956001 Firmonertinib Versus Platinum Based Chemotherapy as First-line Treatment for NSCLC With… EGFR Recruiting
NCT06970639 A Study Evaluating Furmonertinib Plus Platinum-based Doublet Chemotherapy Versus… NSCLC Patients With Brain Metastasis Recruiting
Phase 2
NCT07398339 Cosiporfin Sodium for Injection Photodynamic Therapy Biliary Tract Cancers (BTC) Recruiting
NCT07618910 Retlirafusp Alfa Plus Chemotherapy as Neoadjuvant Therapy for Thoracic ESCC Esophageal Squamous Cell Carcinoma Not Yet Recruiting
Sponsors Running Cisplatin for injection Trials
Allist Pharmaceuticals, Inc. (2) Shanghai Guangsheng Biopharmaceutical Co., Ltd (1) Tang-Du Hospital (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (1) Cholangiocarcinoma (1)
Get alerts when Cisplatin for injection trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free